Skip to main content
SpringerLink
Log in
Book cover

Textbook of Pulmonary Rehabilitation pp 379–390Cite as

Pulmonary Rehabilitation in Restrictive Thoracic Disorders

  • Chapter
  • First Online:

  • 2256 Accesses

Abstract

The interstitial lung diseases (ILDs) are a group of over 200 debilitating conditions characterised by lung inflammation and/or fibrosis. Idiopathic pulmonary fibrosis (IPF), the most common and lethal of the ILDs, accounts for approximately one-third of the ILDs and has a median survival of 3 years from diagnosis [1]. However, the clinical course varies widely and some patients with IPF will experience long periods of stability, whilst others will have frequent exacerbations or a rapid decline [2]. Interstitial lung disease may also occur due to an underlying systemic disease process, such as connective tissue disease or sarcoidosis, or an occupational exposure, such as asbestosis or silicosis. The incidence of ILD is increasing globally, largely due to a rise in the number of people who are diagnosed with IPF. Idiopathic pulmonary fibrosis is a disease of older people, with an estimated prevalence of 19 per 100,000 in those aged 55–64 years, rising to 88 per 100,000 in those 75 and over [3]. Consequently there will be more people living with IPF as the population ages in developed nations.

This is a preview of subscription content, log in via an institution.

References

  1. NICE. The diagnosis and management of suspected idiopathic pulmonary fibrosis: NICE clinical guideline, vol. 163. United Kingdom: National Institute for Health and Care Excellence; 2013.

    Google Scholar 

  2. Ley B, Collard HR, King TE Jr. Clinical course and prediction of survival in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2011;183(4):431–40.

    Article  PubMed  Google Scholar 

  3. Raghu G, Weycker D, Edelsberg J, Bradford WZ, Oster G. Incidence and prevalence of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2006;174(7):810–6.

    Article  PubMed  Google Scholar 

  4. Agusti AG, Roca J, Gea J, Wagner PD, Xaubet A, Rodriguez-Roisin R. Mechanisms of gas-exchange impairment in idiopathic pulmonary fibrosis. Am Rev Respir Dis. 1991;143(2):219–25.

    Article  CAS  PubMed  Google Scholar 

  5. Hansen JE, Wasserman K. Pathophysiology of activity limitation in patients with interstitial lung disease. Chest. 1996;109(6):1566–76.

    Article  CAS  PubMed  Google Scholar 

  6. Swigris JJ, Stewart AL, Gould MK, Wilson SR. Patients’ perspectives on how idiopathic pulmonary fibrosis affects the quality of their lives. Health Qual Life Outcomes. 2005;3:61.

    Article  PubMed  PubMed Central  Google Scholar 

  7. Cottin V, Cordier JF. Velcro crackles: the key for early diagnosis of idiopathic pulmonary fibrosis? Eur Respir J. 2012;40(3):519–21.

    Article  PubMed  Google Scholar 

  8. Mendoza L, Gogali A, Shrikrishna D, Cavada G, Kemp SV, Natanek SA, Jackson AS, Polkey MI, Wells AU, Hopkinson NS. Quadriceps strength and endurance in fibrotic idiopathic interstitial pneumonia. Respirology. 2014;19(1):138–43.

    Article  PubMed  Google Scholar 

  9. Spruit MA, Thomeer MJ, Gosselink R, Troosters T, Kasran A, Debrock AJ, Demedts MG, Decramer M. Skeletal muscle weakness in patients with sarcoidosis and its relationship with exercise intolerance and reduced health status. Thorax. 2005;60(1):32–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Marcellis RG, Lenssen AF, Elfferich MD, De Vries J, Kassim S, Foerster K, Drent M. Exercise capacity, muscle strength and fatigue in sarcoidosis. Eur Respir J. 2011;38(3):628–34.

    Article  CAS  PubMed  Google Scholar 

  11. Madsen OR, Egsmose C, Hansen B, Sorensen OH. Soft tissue composition, quadriceps strength, bone quality and bone mass in rheumatoid arthritis. Clin Exp Rheumatol. 1998;16(1):27–32.

    PubMed  CAS  Google Scholar 

  12. Watanabe, F., H. Taniguchi, K. Sakamoto, Y. Kondoh, T. Kimura, K. Kataoka, T. Ogawa, S. Arizono, O. Nishiyama, and Y. Hasegawa, Quadriceps weakness contributes to exercise capacity in nonspecific interstitial pneumonia.. Respir Med, 2013;107(4):622-628.

    Google Scholar 

  13. Mengshoel AM, Jokstad K, Bjerkhoel F. Associations between walking time, quadriceps muscle strength and cardiovascular capacity in patients with rheumatoid arthritis and ankylosing spondylitis. Clin Rheumatol. 2004;23(4):299–305.

    Article  PubMed  Google Scholar 

  14. Kramer HR, Fontaine KR, Bathon JM, Giles JT. Muscle density in rheumatoid arthritis: associations with disease features and functional outcomes. Arthritis Rheum. 2012;64(8):2438–50.

    Article  PubMed  PubMed Central  Google Scholar 

  15. Marighela TF, Genaro Pde S, Pinheiro MM, Szejnfeld VL, Kayser C. Risk factors for body composition abnormalities in systemic sclerosis. Clin Rheumatol. 2013;32(7):1037–44.

    Article  PubMed  Google Scholar 

  16. Wallaert B, Monge E, Le Rouzic O, Wemeau-Stervinou L, Salleron J, Grosbois JM. Physical activity in daily life of patients with fibrotic idiopathic interstitial pneumonia. Chest. 2013;144(5):1652–8.

    Article  PubMed  Google Scholar 

  17. Bahmer T, Kirsten AM, Waschki B, Rabe KF, Magnussen H, Kirsten D, Gramm M, Hummler S, Brunnemer E, Kreuter M, Watz H. Clinical correlates of reduced physical activity in idiopathic pulmonary fibrosis. Respiration. 2016;91(6):497–502.

    Article  PubMed  Google Scholar 

  18. Collard HR, Ward AJ, Lanes S, Cortney Hayflinger D, Rosenberg DM, Hunsche E. Burden of illness in idiopathic pulmonary fibrosis. J Med Econ. 2012;15(5):829–35.

    Article  PubMed  Google Scholar 

  19. King C, Nathan SD. Identification and treatment of comorbidities in idiopathic pulmonary fibrosis and other fibrotic lung diseases. Curr Opin Pulm Med. 2013;19(5):466–73.

    Article  PubMed  Google Scholar 

  20. King CS, Nathan SD. Idiopathic pulmonary fibrosis: effects and optimal management of comorbidities. Lancet Respir Med. 2017;5(1):72–84.

    Article  PubMed  Google Scholar 

  21. Holland AE, Fiore JF Jr, Bell EC, Goh N, Westall G, Symons K, Dowman L, Glaspole I. Dyspnoea and comorbidity contribute to anxiety and depression in interstitial lung disease. Respirology. 2014;19(8):1215–21.

    Article  PubMed  Google Scholar 

  22. Ryerson CJ, Arean PA, Berkeley J, Carrieri-Kohlman VL, Pantilat SZ, Landefeld CS, Collard HR. Depression is a common and chronic comorbidity in patients with interstitial lung disease. Respirology. 2012;17(3):525–32.

    Article  PubMed  Google Scholar 

  23. Kreuter M, Ehlers-Tenenbaum S, Palmowski K, Bruhwyler J, Oltmanns U, Muley T, Heussel CP, Warth A, Kolb M, Herth FJ. Impact of comorbidities on mortality in patients with idiopathic pulmonary fibrosis. PLoS One. 2016;11(3):e0151425.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. King TE Jr, Bradford WZ, Castro-Bernardini S, Fagan EA, Glaspole I, Glassberg MK, Gorina E, Hopkins PM, Kardatzke D, Lancaster L, Lederer DJ, Nathan SD, Pereira CA, Sahn SA, Sussman R, Swigris JJ, Noble PW, A.S. Group. A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis. N Engl J Med. 2014;370(22):2083–92.

    Article  CAS  PubMed  Google Scholar 

  25. Richeldi L, du Bois RM, Raghu G, Azuma A, Brown KK, Costabel U, Cottin V, Flaherty KR, Hansell DM, Inoue Y, Kim DS, Kolb M, Nicholson AG, Noble PW, Selman M, Taniguchi H, Brun M, Le Maulf F, Girard M, Stowasser S, Schlenker-Herceg R, Disse B, Collard HR, Investigators IT. Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis. N Engl J Med. 2014;370(22):2071–82.

    Article  CAS  PubMed  Google Scholar 

  26. Raghu G, Collard HR, Egan JJ, Martinez FJ, Behr J, Brown KK, Colby TV, Cordier JF, Flaherty KR, Lasky JA, Lynch DA, Ryu JH, Swigris JJ, Wells AU, Ancochea J, Bouros D, Carvalho C, Costabel U, Ebina M, Hansell DM, Johkoh T, Kim DS, King TE Jr, Kondoh Y, Myers J, Muller NL, Nicholson AG, Richeldi L, Selman M, Dudden RF, Griss BS, Protzko SL, Schunemann HJ. An Official ATS/ERS/JRS/ALAT Statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med. 2011;183(6):788–824.

    Article  PubMed  PubMed Central  Google Scholar 

  27. Bradley B, Branley HM, Egan JJ, Greaves MS, Hansell DM, Harrison NK, Hirani N, Hubbard R, Lake F, Millar AB, Wallace WA, Wells AU, Whyte MK, Wilsher ML. Interstitial lung disease guideline: the British Thoracic Society in collaboration with the Thoracic Society of Australia and New Zealand and the Irish Thoracic Society. Thorax. 2008;63(Suppl 5):v1–58.

    PubMed  Google Scholar 

  28. Spruit MA, Singh SJ, Garvey C, ZuWallack R, Nici L, Rochester C, Hill K, Holland AE, Lareau SC, Man WD, Pitta F, Sewell L, Raskin J, Bourbeau J, Crouch R, Franssen FM, Casaburi R, Vercoulen JH, Vogiatzis I, Gosselink R, Clini EM, Effing TW, Maltais F, van der Palen J, Troosters T, Janssen DJ, Collins E, Garcia-Aymerich J, Brooks D, Fahy BF, Puhan MA, Hoogendoorn M, Garrod R, Schols AM, Carlin B, Benzo R, Meek P, Morgan M, Rutten-van Molken MP, Ries AL, Make B, Goldstein RS, Dowson CA, Brozek JL, Donner CF, Wouters EF. An official American Thoracic Society/European Respiratory Society statement: key concepts and advances in pulmonary rehabilitation. Am J Respir Crit Care Med. 2013;188(8):e13–64.

    Article  PubMed  Google Scholar 

  29. Dowman L, Hill CJ, Holland AE. Pulmonary rehabilitation for interstitial lung disease. Cochrane Database Syst Rev. 2014;10:CD006322.

    Google Scholar 

  30. McCarthy B, Casey D, Devane D, Murphy K, Murphy E, Lacasse Y. Pulmonary rehabilitation for chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2015;2:CD003793.

    Google Scholar 

  31. Holland AE, Hill CJ, Conron M, Munro P, McDonald CF. Short term improvement in exercise capacity and symptoms following exercise training in interstitial lung disease. Thorax. 2008;63(6):549–54.

    Article  CAS  PubMed  Google Scholar 

  32. Vainshelboim B, Oliveira J, Fox BD, Soreck Y, Fruchter O, Kramer MR. Long-term effects of a 12-week exercise training program on clinical outcomes in idiopathic pulmonary fibrosis. Lung. 2015;193(3):345–54.

    Article  PubMed  Google Scholar 

  33. Spruit MA, Pitta F, Garvey C, ZuWallack RL, Roberts CM, Collins EG, Goldstein R, McNamara R, Surpas P, Atsuyoshi K, Lopez-Campos JL, Vogiatzis I, Williams JE, Lareau S, Brooks D, Troosters T, Singh SJ, Hartl S, Clini EM, Wouters EF, E.R.S. Rehabilitation, C. Chronic, G. Physiotherapists Scientific, C. American Association of, R. Pulmonary, A.T.S.P.R. Assembly, and E.R.S. C.OPD Audit team. Differences in content and organisational aspects of pulmonary rehabilitation programmes. Eur Respir J. 2014;43(5):1326–37.

    Article  PubMed  Google Scholar 

  34. Bolton CE, Bevan-Smith EF, Blakey JD, Crowe P, Elkin SL, Garrod R, Greening NJ, Heslop K, Hull JH, Man WD, Morgan MD, Proud D, Roberts CM, Sewell L, Singh SJ, Walker PP, Walmsley S, G. British Thoracic Society Pulmonary Rehabilitation Guideline Development, and C. British Thoracic Society Standards of Care. British Thoracic Society guideline on pulmonary rehabilitation in adults. Thorax. 2013;68(Suppl 2):ii1–30.

    Article  PubMed  Google Scholar 

  35. Borg G. Psycho physical bases of perceived exertion. Med Sci Sports Exerc. 1982;14(5):377–81.

    Article  CAS  PubMed  Google Scholar 

  36. Jenkins S, Cecins N. Six-minute walk test: observed adverse events and oxygen desaturation in a large cohort of patients with chronic lung disease. Intern Med J. 2011;41(5):416–22.

    Article  CAS  PubMed  Google Scholar 

  37. Glaser S, Noga O, Koch B, Opitz CF, Schmidt B, Temmesfeld B, Dorr M, Ewert R, Schaper C. Impact of pulmonary hypertension on gas exchange and exercise capacity in patients with pulmonary fibrosis. Respir Med. 2009;103(2):317–24.

    Article  PubMed  Google Scholar 

  38. Pouwels-Fry S, Pouwels S, Fournier C, Duchemin A, Tillie-Leblond I, Le Tourneau T, Wallaert B. Effects of oxygen on exercise-induced increase of pulmonary arterial pressure in idiopathic pulmonary fibrosis. Sarcoidosis Vasc Diffuse Lung Dis. 2008;25(2):133–9.

    PubMed  CAS  Google Scholar 

  39. Holland AE, Fiore JF Jr, Goh N, Symons K, Dowman L, Westall G, Hazard A, Glaspole I. Be honest and help me prepare for the future: what people with interstitial lung disease want from education in pulmonary rehabilitation. Chron Respir Dis. 2015;12(2):93–101.

    Article  PubMed  Google Scholar 

  40. Holland AE, Spruit MA, Troosters T, Puhan MA, Pepin V, Saey D, McCormack MC, Carlin BW, Sciurba FC, Pitta F, Wanger J, MacIntyre N, Kaminsky DA, Culver BH, Revill SM, Hernandes NA, Andrianopoulos V, Camillo CA, Mitchell KE, Lee AL, Hill CJ, Singh SJ. An official European Respiratory Society/American Thoracic Society Technical Standard: field walking tests in chronic respiratory disease. Eur Respir J. 2014;44(6):1428–46.

    Article  PubMed  Google Scholar 

  41. Ambrosino N, Carpenè N, Gherardi M. Chronic respiratory care in neuromuscular diseases for adults. Eur Respir J. 2009;34(2):444–51.

    Article  CAS  PubMed  Google Scholar 

  42. Fiorenza D, Vitacca M, Bianchi L, Gabbrielli L, Ambrosino N. Lung function and disability in neuromuscular patients at first admission to a respiratory clinic. Respir Med. 2011;105(1):151–8.

    Article  PubMed  Google Scholar 

  43. Bushby K, Finkel R, Birnkrant DJ, Case LE, Clemens PR, Cripe L, Kaul A, Kinnett K, McDonald C, Pandya S, Poysky J, Shapiro F, Tomezsko J, Constantin C, DMD Care Considerations Working Group. Diagnosis and management of Duchenne muscular dystrophy. Part 2: Implementation of multidisciplinary care. Lancet Neurol. 2010;9(2):177–89.

    Article  CAS  PubMed  Google Scholar 

  44. Ambrosino N, Confalonieri M, Crescimanno G, Vianello A, Vitacca M. The role of respiratory Management of Pompe disease. Respir Med. 2013;107(8):1124–32.

    Article  PubMed  Google Scholar 

  45. Vry J, Gramsch K, Rodger S, Thompson R, Steffensen BF, Rahbek J, Doerken S, Tassoni A, Beytía ML, Guergueltcheva V, Chamova T, Tournev I, Kostera-Pruszczyk A, Kaminska A, Lusakowska A, Mrazova L, Pavlovska L, Strenkova J, Vondráček P, Garami M, Karcagi V, Herczegfalvi Á, Bushby K, Lochmüller H, Kirschner J. European cross-sectional survey of current care practices for Duchenne Muscular Dystrophy reveals regional and age-dependent differences. J Neuromuscul Dis. 2016;3(4):517–27.

    Article  PubMed  PubMed Central  Google Scholar 

  46. Bach JR. Noninvasive respiratory management of high level spinal cord injury. J Spinal Cord Med. 2012;35(2):72–80.

    Article  PubMed  PubMed Central  Google Scholar 

  47. Dail C, Rodgers M, Guess V, Adkins HV. Glossopharyngeal breathing. Downey, CA: Rancho Los Amigos Department of Physical Therapy; 1979.

    Google Scholar 

  48. Webber B, Higgens J. Glossopharyngeal breathing: what, when and how? [video]. West Sussex, England: Aslan Studios Ltd., Holbrook, Horsham; 1999.

    Google Scholar 

  49. Strickland SL, Rubin BK, Drescher GS, Haas CF, O'Malley CA, Volsko TA, Branson RD, Hess DR, American Association for Respiratory Care, Irving, Texas. AARC Clinical Practice Guideline: effectiveness of nonpharmacologic airway clearance therapies in hospitalized patients. Respir Care. 2013;58(12):2187–93.

    Article  PubMed  Google Scholar 

  50. McIlwaine M, Bradley J, Elborn JS, Moran F. Personalising airway clearance in chronic lung disease. Eur Respir Rev. 2017;26(143) doi:10.1183/16000617.0086-2016.

  51. Gosselink R. Respiratory physiotherapy. In: Donner CF, Ambrosino N, Goldstein RS, editors. Pulmonary rehabilitation. London: Hodder Arnold; 2005. p. 186–94.

    Chapter  Google Scholar 

  52. Kang SW, Bach JR. Maximum insufflation capacity: vital capacity and cough flows in neuromuscular disease. Am J Phys Med Rehabil. 2000;79(3):222–7.

    Article  CAS  PubMed  Google Scholar 

  53. Chiou M, Bach JR, Jethani L, Gallagher MF. Active lung volume recruitment to preserve vital capacity in Duchenne Muscular Distrophy. J Rehabil Med. 2017;49(1):49–53.

    Article  PubMed  Google Scholar 

  54. Suri P, Burns SP, Bach JR. Pneumothorax associated with mechanical insufflation-exsufflation and related factors. Am J Phys Med Rehabil. 2008;87(11):951–5.

    Article  PubMed  Google Scholar 

  55. Venturelli E, Crisafulli E, DeBiase A, Righi D, Berrighi D, Cavicchioli PP, Vagheggini G, Dabrosca F, Balbi B, Paneroni M, Bianchi L, Vitacca M, Galimberti V, Zaurino M, Schiavoni G, Iattoni A, Ambrosino N, Clini EM. Efficacy of temporary positive expiratory pressure (TPEP) in patients with lung diseases and chronic mucus hypersecretion. The UNIKO® project. Clin Rehabil. 2013;27(4):336–46.

    Article  PubMed  Google Scholar 

  56. Guarracino F, Bertini P, Bortolotti U, Stefani M, Ambrosino N. Flexible bronchoscopy during mechanical ventilation in the prone position to treat acute lung injury. Rev Port Pneumol. 2013;19(1):42–4.

    Article  CAS  PubMed  Google Scholar 

  57. Strickland SL, Rubin BK, Haas CF, Volsko TA, Drescher GS, O'Malley CA. AARC Clinical Practice Guideline: effectiveness of pharmacologic airway clearance therapies in hospitalized patients. Respir Care. 2015;60(7):1071–7.

    Article  PubMed  Google Scholar 

  58. Katz SL, Barrowman N, Monsour A, Su S, Hoey L, McKim D. Long-term effects of lung volume recruitment on maximal inspiratory capacity and vital capacity in Duchenne muscular dystrophy. Ann Am Thorac Soc. 2016;13(2):217–22.

    PubMed  Google Scholar 

  59. Bach JR. Mechanical insufflation-exsufflation. Comparison of peak expiratory flows with manually assisted and unassisted coughing techniques. Chest. 1993;104(5):1553–62.

    Article  CAS  PubMed  Google Scholar 

  60. Vianello A, Corrado A, Arcaro G, Gallan F, Ori C, Minuzzo M, Bevilacqua M. Mechanical insufflation exsufflation improves outcomes for neuromuscular disease patients with respiratory tract infections. Am J Phys Med Rehabil. 2005;84(2):83–8.

    Article  PubMed  Google Scholar 

  61. Lee JW, Won YH, Kim DH, Choi WA, Bach JR, Kim DJ, Kang SW. Pulmonary rehabilitation to decrease perioperative risks of spinal fusion for patients with neuromuscular scoliosis and low vital capacity. Eur J Phys Rehabil Med. 2016;52(1):28–35.

    PubMed  Google Scholar 

  62. Goncalves MR, Honrado T, Winck JC, Paiva JA. Effects of mechanical insufflation-exsufflation in preventing respiratory failure after extubation: a randomized controlled trial. Crit Care. 2012;16(2):R48.

    Article  PubMed  PubMed Central  Google Scholar 

  63. Bach JR, Goncalves MR, Hamdani I, Winck JC. Extubation of patients with neuromuscular weakness: a new management paradigm. Chest. 2010;137(5):1033–9.

    Article  PubMed  Google Scholar 

  64. Auger C, Hernando V, Galmiche H. Use of mechanical insufflation-exsufflation devices for airway clearance in subjects with neuromuscular disease. Respir Care. 2017;62(2):236–45.

    Article  PubMed  Google Scholar 

  65. Narayanaswami P, Weiss M, Selcen D, David W, Raynor E, Carter G, Wicklund M, Barohn RJ, Ensrud E, Griggs RC, Gronseth G, Amato AA. Evidence-based guideline summary: diagnosis and treatment of limb-girdle and distal dystrophies: report of the guideline development subcommittee of the American Academy of Neurology and the practice issues review panel of the American Association of Neuromuscular & Electrodiagnostic Medicine. Neurology. 2014;83(16):1453–63.

    Article  PubMed  PubMed Central  Google Scholar 

  66. Boentert M, Prigent H, Várdi K, Jones HN, Mellies U, Simonds AK, Wenninger S, Barrot Cortés E, Confalonieri M. Practical recommendations for diagnosis and management of respiratory muscle weakness in late-onset Pompe Disease. Int J Mol Sci. 2016;17(10.) pii: E1735

    Google Scholar 

  67. Aslan GK, Gurses HN, Issever H, Kiyan E. Effects of respiratory muscle training on pulmonary functions in patients with slowly progressive neuromuscular disease: a randomized controlled trial. Clin Rehabil. 2014;28(6):573–81.

    Article  PubMed  Google Scholar 

  68. Eidenberger M, Nowotny S. Inspiratory muscle training in patients with amyotrophic lateral sclerosis: a systematic review. NeuroRehabilitation. 2014;35(3):349–61.

    PubMed  Google Scholar 

  69. Garuti G, Bagatti S, Verucchi E, Massobrio M, Spagnolatti L, Vezzani G, Lusuardi M. Pulmonary rehabilitation at home guided by telemonitoring and access to healthcare facilities for respiratory complications in patients with neuromuscular disease. Eur J Phys Rehabil Med. 2013;49(1):51–7.

    PubMed  CAS  Google Scholar 

  70. Ambrosino N, Vitacca M, Dreher M, Isetta V, Montserrat JM, Tonia T, Turchetti G, Winck JC, Burgos F, Kampelmacher M, Vagheggini G, ERS Tele-Monitoring of Ventilator-Dependent Patients Task Force. Tele-monitoring of ventilator-dependent patients: a European Respiratory Society Statement. Eur Respir J. 2016;48(3):648–63.

    Article  PubMed  Google Scholar 

  71. Ambrosino N, Makhabah DN. Tele-medicine: a new promised land, just to save resources? Eur Respir J. 2017;49:1700410.

    Google Scholar 

  72. Escarrabil J, Vianello A, Farrero E, Ambrosino N, Martínez LJ, Vitacca M. Place of death in patients with amyotrophic lateral sclerosis. Rev Port Pneumol. 2014;20(4):188–93.

    Article  Google Scholar 

  73. Lloyd-Owen SJ, Donaldson GC, Ambrosino N, Escarabill J, Farre R, Fauroux B, Robert D, Schoenhofer B, Simonds AK, Wedzicha JA. Patterns of home mechanical ventilation use in Europe: results from the Eurovent survey. Eur Respir J. 2005;25(6):1025–31.

    Article  CAS  PubMed  Google Scholar 

  74. Vitacca M, Grassi M, Barbano L, Galavotti G, Sturani C, Vianello A, Zanotti E, Ballerin L, Potena A, Scala R, Peratoner A, Ceriana P, Di Buono L, Clini E, Ambrosino N, Hill N, Nava S. Last 3 months of life in home-ventilated patients: the family perception. Eur Respir J. 2010;35(5):1064–71.

    Article  CAS  PubMed  Google Scholar 

  75. Di Paolo M, Evangelisti L, Ambrosino N. Unexpected death of a ventilator-dependent ALS patient. Rev Port Pneumol. 2013;19(4):175–8.

    Article  PubMed  Google Scholar 

  76. Winck J, Camacho R, Ambrosino N. Multidisciplinary rehabilitation in ventilator-dependent patients: call for action in specialized inpatients facilities. Rev Port Pneumol (2006). 2015; doi:10.1016/j.rppnen.2015.03.005.

  77. Barawid E, Covarrubias N, Tribuzio B, Liao S. The benefits of rehabilitation for palliative care patients. Am J Hosp Palliat Care. 2015;32(1):34–43.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Alfred Health and Institute for Breathing and Sleep, La Trobe University, Melbourne, Australia

    Anne Holland

  2. Research Consultant, Pulmonary and Respiratory Medicine Department, Faculty of Medicine, Universitas Sebelas Maret, Surakarta, Indonesia

    Nicolino Ambrosino

  3. Istituti Clinici Scientifici Maugeri, Scientific Institute of Montescano, Montescano, Italy

    Nicolino Ambrosino

Authors
  1. Anne Holland
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Nicolino Ambrosino
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Nicolino Ambrosino .

Editor information

Editors and Affiliations

  1. Department of Medical and Surgical Sciences, University of Modena, Azienda Ospedaliero Universitaria di Modena Policlinico, Modena, Italy

    Enrico Clini

  2. Alfred Health and Institute for Breathing and Sleep, La Trobe University, Melbourne, Australia

    Anne E. Holland

  3. State University of Londrina, Londrina, Paraná, Brazil

    Fabio Pitta

  4. Department of Rehabilitation Sciences, KU Leuven, Respiratory Division and Rehabilitation, University Hospital Leuven, Leuven, Belgium

    Thierry Troosters

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Holland, A., Ambrosino, N. (2018). Pulmonary Rehabilitation in Restrictive Thoracic Disorders. In: Clini, E., Holland, A., Pitta, F., Troosters, T. (eds) Textbook of Pulmonary Rehabilitation. Springer, Cham. https://doi.org/10.1007/978-3-319-65888-9_28

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-65888-9_28

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-65887-2

  • Online ISBN: 978-3-319-65888-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation